Xue‐Qiao Zhao

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction

Yue Zhang, Xiaosong Ding, Bing Hua et al. · Nutrition Metabolism and Cardiovascular Diseases · 2020 · 156 citations · Full text

Medicine, Cardiology, Internal Medicine +14

High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L

Yue Zhang, Xiaosong Ding, Bing Hua et al. · Journal of Atherosclerosis and Thrombosis · 2021 · 91 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction

Wen Su, Xue‐Qiao Zhao, Man Wang et al. · Journal of Cardiology · 2018 · 44 citations

Medicine, Cardiology, Internal Medicine +16

Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure

Dennis D. Wang, Anna Naumova, Daniel Isquith et al. · Cardiovascular Diabetology · 2024 · 44 citations · Full text

Medicine, Cardiology, Pharmacology +17